Temple University Health System: Researchers Find RIPK3 Silencing Contributes to Chemoresistance in Malignant Mesothelioma

Press/Media

PeriodMar 29 2021

Media coverage

1

Media coverage

  • TitleTemple University Health System: Researchers Find RIPK3 Silencing Contributes to Chemoresistance in Malignant Mesothelioma
    Media name/outletIndia Pharma News
    Country/TerritoryIndia
    Date03/29/21
    PersonsSiddharth Balachandran, Joseph R. Testa
View all 1
View less